James L. Winkle College of Pharmacy, University of Cincinnati Academic Health Center, Cincinnati, OH 45267, USA.
The Procter & Gamble Company, Cincinnati, OH, USA.
J Control Release. 2015 Oct 28;216:1-8. doi: 10.1016/j.jconrel.2015.07.032. Epub 2015 Aug 1.
A method is presented for measuring the lateral diffusion coefficients of exogenously applied compounds on excised skin. The method involves sequential high resolution imaging of the spatial distribution of β-radiation associated with [(14)C]-labeled compounds to monitor the development of the concentration profile on the skin surface. It is exemplified by measurements made on three radiolabeled test compounds--caffeine, testosterone, and zinc pyrithione (ZnPT)--administered as solutions. Lateral diffusivity is expected to be an important determinant of the topical bioavailability of ZnPT, which is characteristically administered as a fine suspension and must reach microorganisms in molecular form to exert biocidal activity. Application of the test compounds at levels below and above their estimated saturation doses in the upper stratum corneum allows one to distinguish between diffusion-limited and dissolution rate-limited kinetics. The effective lateral diffusivities of the two chemically stable reference compounds, caffeine and testosterone, were (1-4) × 10(-9) cm(2)/s and (3-9) × 10(-9) cm(2)/s, respectively. Lateral transport of [(14)C] associated with ZnPT was formulation-dependent, with effective diffusivities of (1-2) × 10(-9) cm(2)/s in water and (3-9) × 10(-9) cm(2)/s in a 1% body wash solution. These differences are thought to be related to molecular speciation and/or the presence of a residual surfactant phase on the skin surface. All values were greater than those estimated for the transverse diffusivities of these compounds in stratum corneum by factors ranging from 250 to over 2000. Facile lateral transport on skin, combined with a low transdermal permeation rate, may thus be seen to be a key factor in the safe and effective use of ZnPT as a topical antimicrobial agent.
本文提出了一种测量离体皮肤表面外源化合物横向扩散系数的方法。该方法通过对与[(14)C]标记化合物相关的β-射线的空间分布进行连续高分辨率成像,监测皮肤表面浓度分布的发展情况。以三种放射性标记的测试化合物——咖啡因、睾丸酮和吡啶硫酮锌(ZnPT)——作为溶液给药为例进行了说明。横向扩散系数有望成为 ZnPT 局部生物利用度的重要决定因素,ZnPT 通常以细悬浮液的形式给药,必须以分子形式到达微生物才能发挥杀菌活性。在高于和低于其在上表皮角质层中的估计饱和剂量的水平下应用测试化合物,可以区分扩散受限和溶解速率受限的动力学。两种化学稳定的参考化合物——咖啡因和睾丸酮的有效横向扩散系数分别为(1-4)×10(-9)cm(2)/s 和(3-9)×10(-9)cm(2)/s。与 ZnPT 相关的[(14)C]的横向传输与制剂有关,在水中的有效扩散系数为(1-2)×10(-9)cm(2)/s,在 1%体香波溶液中的有效扩散系数为(3-9)×10(-9)cm(2)/s。这些差异被认为与分子形态和/或皮肤表面残留的表面活性剂相有关。所有这些值都大于通过角蛋白层中这些化合物的横向扩散系数的估计值的 250 到 2000 倍以上。在皮肤表面的横向传输很容易,加上透皮渗透速率低,因此可以认为是安全有效使用 ZnPT 作为局部抗菌剂的关键因素。